米非司酮配伍新生化颗粒药物流产的临床疗效观察

Clinical Observation of Mifepristone Combined With New Biochemical Particles in Drug Abortion

目的探究米非司酮配伍新生化颗粒药物流产的临床疗效。方法选择2015年4月-2016年4月在我院进行药物流产的145例患者为研究对象,采用随机数法分为观察组和对照组,对照组采用米非司酮和米索前列醇流产,观察组在此基础上配伍新生化颗粒。对比两组的流产相关情况。结果观察组患者在阴道流血时间和月经恢复时间、阴道出血量及完全流产率等指标方面优于对照组患者,差异具有统计学意义（P〈0.05）。结论米非司酮配伍新生化颗粒药物流产能够提升完全流产率、优化患者各项临床指标,效果显著。

Objective To explore the clinical effect of mifepristone compatibility new biological particles drug abortion. Methods 145 patients of medical abortion were chosen from April 2015 and April 2016 in our hospital as the research object, by using random divided into observation group and control group, control group using mifepristone and misoprostol abortion, observation group based on the combination of new biological particles. Comparison of two groups of abortion. Results Patients in the observation group were better than the control group, the difference was statistically significant（P〈0.05） in the vaginal bleeding time and the recovery time of menstruation, vaginal bleeding and complete abortion rate. Conclusion Mifepristone combined with new biochemical particles of drug abortion can improve the rate of complete abortion, optimize the clinical indicators of patients, the effect is significant.